Fallopian tube disorder
Therapeutic area
Reproductive Health
Rare disease
No
- Definition
- A disease involving the fallopian tube.
- Genetic basis
- No
- Non-human condition
- No
- Rare disease
- No
- Listing at source
- Listed
- Condition name
- Fallopian tube disorder
- Therapeutic area
- Reproductive Health
- fallopian tube disorder
- disease of fallopian tube
- disease or disorder of fallopian tube
- disorder of fallopian tube
- fallopian tube disease
- fallopian tube disease or disorder
- fallopian tube disorder
- All therapeutic areas
- Reproductive Health
- Severity
- Moderate
- MONDO ID
- MONDO:0002156
- Parent condition
- MONDO:0002263
Related records
Broader conditions (5)
- Disease
- Disease by body system or component
- Female reproductive system disorder
- Human disease
- Reproductive system disorder
Narrower conditions (45)
- Acute gonococcal salpingitis
- Acute salpingitis
- Acute salpingo-oophoritis
- Cancer of isthmus of fallopian tube
- Chronic gonococcal salpingitis
- Chronic salpingitis
- Chronic salpingo-oophoritis
- Embryonic cyst of fallopian tube
- Fallopian tube adenocarcinoma
- Fallopian tube adenomatoid tumor
- Fallopian tube adenosarcoma
- Fallopian tube benign neoplasm
- Fallopian tube cancer
- Fallopian tube carcinoma
- Fallopian tube carcinosarcoma
- Fallopian tube clear cell adenocarcinoma
- Fallopian tube cystadenofibroma
- Fallopian tube endometrioid adenocarcinoma
- Fallopian tube endometrioid tumor
- Fallopian tube endometriosis
Trials (23)
- A Phase I Study of WT1 or NY-ESO-1 Vaccine and Nivolumab For Recurrent Ovarian Cancer
- A Study of Carboplatin and Paclitaxel Chemotherapy With Nivolumab With or Without Ipilimumab in Patients With Ovarian Cancer
- A Study to Evaluate the Combination of ATX-101 and Platinum-based Chemotherapy
- Antispasmodic Drug for Diagnosis Proximal Tubal Occlusion on Hysterosalpingography
- Assessment of Tubal Occlusion During Minimally Invasive Myomectomy
- Determinants of Age-Related Treatment Effectiveness in Ovarian Cancer
- Effect of Laser Acupoints on Fallopian Tube Obstruction
- Enzalutamide in Patients With Androgen Receptor Positive (AR+) Ovarian, Primary Peritoneal or Fallopian Tube Cancer and One, Two or Three Prior Therapies
- Evaluating a Novel Onco-genetic BRCA Testing Counselling Model Among Patients With Ovarian Cancer
- Fertility Restoration Using Autologous Mesenchymal Stem Cells
- Hysteroscopic Versus Laparoscopic Tubal Occlusion in Cases of Hydrosalpinx and Planning for IVF
- Intraoperative Detection of Lesions Using PET (Positron Emission Tomography) Probe During Secondary Cytoreductive Surgery for Recurrent Ovarian, Fallopian Tube and Primary Peritoneal Cancer
- Neural Therapy Effect and Bilateral Tubal Ligation
- Oregovomab and PLD in PARP Inhibitor Resistant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Patients Not Candidate for Platinum Retreatment
- Phase I Pilot Study of Biodistribution, Metabolism and Excretion of Novel Radiotracer [18F]Fluorthanatrace (FTT) by PET/CT
- Prevalence of HbA1C in Women With PCOS
- Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers
- Safety and Immunogenicity of Innocell Autologous Cellular Immunotherapy for Recurrent Epithelial Ovarian Cancer
- Study of ABT-767 in Subjects With Breast Cancer 1 and Breast Cancer 2 (BRCA 1 and BRCA 2) Mutations and Solid Tumors or High Grade Serous Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
- Study of Carboplatin and Mirvetuximab Soravtansine in First-Line Treatment of Patients Receiving Neoadjuvant Chemotherapy With Advanced-Stage Ovarian, Fallopian Tube or Primary Peritoneal Cancer